ArticleNMR in biomedicine2014

Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.

J P Wijnen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.